Species clarity
Kava and kratom are not the same thing
Kava and kratom get mentioned in the same breath so often — same shops, same conversations, sometimes the same drink menus — that many people assume they're related. They share almost nothing: not family, not geography, not chemistry, not mechanism, not regulatory posture. Conflating them is more than a botanical error; it makes every safety and quality question harder to ask correctly.
Two plants from different worlds
Kava (Piper methysticum, family Piperaceae) is a Pacific Island shrub whose ROOT is the traditional material — prepared as a water-based drink with centuries of documented ceremonial and social use across Fiji, Vanuatu, Tonga, and neighboring cultures. Its studied chemistry centers on kavalactones, with GABA-A-related modulation as a major research focus.
Kratom (Mitragyna speciosa, family Rubiaceae — the coffee family) is a Southeast Asian tree whose LEAF is the traditional material, with a use record from Thailand, Malaysia, and Indonesia. Its chemistry centers on indole alkaloids — mitragynine and 7-hydroxymitragynine — which interact with opioid receptors, a completely different mechanistic territory with a completely different set of research and dependence questions.
Why the confusion is costly
Because the two plants raise different questions, a buyer or clinician who conflates them will ask the wrong ones. Kava's literature conversation includes liver-safety debates and preparation-method distinctions (water-extracted root versus other preparations). Kratom's conversation includes opioid-receptor pharmacology, dependence potential, and an active regulatory debate — the U.S. FDA has issued consumer advisories about it, while several U.S. states have banned or restricted it.
Neither plant's questions apply to the other. A venue selling both as interchangeable "relaxation botanicals" has flattened the single most important distinction its customers need.
The commerce trap: shared shelf, shared vocabulary
Both plants now appear in similar formats — powders, extracts, drinks — described with a shared marketing vocabulary. The format similarity is real; the material similarity is not. As with every botanical: the species, the plant part, the preparation, and the batch documentation are what define the product. The shelf it sits on defines nothing.
Which species is it?
Sources & further reading
Keep reading
Want the evidence itself?
Myto Intelligence maps 1,173 medications to 705plants, fungi & ethnobotanicals by shared mechanism — every result with an evidence tier and a citation. It teaches, compares, and cites; it never tells anyone what to take.